Dm. Thompson et al., A COMPARISON OF LAPAROSCOPIC ULTRASOUND WITH DIGITAL FLUOROCHOLANGIOGRAPHY FOR DETECTING CHOLEDOCHOLITHIASIS DURING LAPAROSCOPIC CHOLECYSTECTOMY, Surgical endoscopy, 12(7), 1998, pp. 929-932
Background: Laparoscopic ultrasound is an alternative to operative cho
langiogram for evaluation of the common bile duct (CBD) during laparos
copic cholecystectomy. It is a safe, fast, and reliable method for det
ecting choledocholithiasis. Methods: We prospectively evaluated the se
nsitivity and specificity of laparoscopic ultrasound (LUS) and digital
fluorocholangiogram (DFCG) in a three-phase study of 360 consecutive
patients. Results: In phase I, 140 patients undergoing laparoscopic ch
olecystectomy had LUS performed first, followed by DFCG. Thirteen pati
ents had CBD calculi identified on LUS. Four patients with confirmed (
two cases) or presumed (two cases) CBD calculi on DFCG were not identi
fied on LUS. Thus, the specificity of LUS was 100%, whereas the sensit
ivity was 76.5%. DFCG had four false positives, for a sensitivity of 1
00% with a specificity of 96.7%. LUS was performed, on average, in 6.6
min, whereas DFCG required 10.9 min to perform. In phase II, the infu
sion of saline through a cystic duct catheter was performed in instanc
es where the distal CBD could not be well seen. This maneuver distende
d the intrapancreatic portion of the CBD, allowing better visualizatio
n. Nine stones were identified on LUS in 78 patients, increasing the s
ensitivity to 100%. One false positive DCFG was encountered, resulting
in a sensitivity of 100% and a specificity of 98.6%. In phase III, we
performed routine LUS and used DFCG only in select cases. The sensiti
vity and specificity for LUS were 95.7% and 100%, respectively, wherea
s DFCG had a sensitivity of 95.2% and a specificity of 100%, One patie
nt in phase In. has returned 11 months post-op with a CBD stone. This
was initially missed on LUS, DFCG, and postoperative ERCP. The sensiti
vity and specificity in all 360 patients were 90% and 100% for LUS and
98.1% and 98.1% for DFCG, respectively. A total of five CBD stones we
re missed by LUS, four early in the study (phase I). One missed on LUS
in phase III was also missed by DFCG and ERCP. Conclusions: LUS is a
reliable alternative to DFCG during laparoscopic cholecystectomy (LC).
With experience, it is as sensitive as DFCG and more specific. It is
more rapidly performed than cholangiography.